Drug-Device Combination s Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
Drug-Device Combination s Market contains market size and forecasts of Drug-Device Combination Products in Global, including the following market information:
Global Drug-Device Combination Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug-Device Combination Products market was valued at 36220 million in 2021 and is projected to reach US$ 54360 million by 2028, at a CAGR of 6.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug-Coated Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug-Device Combination Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug-Device Combination Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug-Device Combination Products Market Segment Percentages, by Type, 2021 (%)
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Global Drug-Device Combination Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug-Device Combination Products Market Segment Percentages, by Application, 2021 (%)
Hospital andClinic
Retail Pharmacies
Other
Global Drug-Device Combination Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug-Device Combination Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug-Device Combination Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug-Device Combination Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma